📰 Breaking News: Lessons Learnt & Insights from DSTBTD Restructuring Plan

Appointment of liquidators (MVL)

Verso Biosense R&D Limited enters members' voluntary liquidation

active Company no. 09890252 Published 28 September 2026

In short: Verso Biosense R&D Limited (company no. 09890252) entered members' voluntary liquidation, a solvent and planned closure, according to a Appointment of liquidators (MVL) notice published in The London Gazette on 28 September 2026. The office holders are Nicola Kate Clark (IP No. 19390) of MHA Advisory Ltd, 80 Mosley Street, Manchester, M2 3FX; Andrew John Duncan (IP No. 9319) of MHA Advisory Ltd, 6th Floor, 2 L, appointed 23 September 2026. The company's business: activities of other holding companies not elsewhere classified.

Verso Biosense R&D Limited has appointed two liquidators, Nicola Kate Clark and Andrew John Duncan, on 23 September 2026 in a members' liquidation.

Notice details

Company
VERSO BIOSENSE R&D LIMITED
Company number
09890252
Nature of business
Activities of other holding companies not elsewhere classified
Registered office
MHA Advisory Ltd, 6th Floor, 2 London Wall Place, London, EC2Y 5AU (Formerly) 115b Innovation Drive, Milton Park, Milton, Abingdon, Oxfordshire, OX14 4RZ
Type of liquidation
Members
Date of appointment
23 September 2026
Liquidator(s)
Nicola Kate Clark (IP No. 19390) of MHA Advisory Ltd, 80 Mosley Street, Manchester, M2 3FX; Andrew John Duncan (IP No. 9319) of MHA Advisory Ltd, 6th Floor, 2 London Wall Place, London, EC2Y 5AU
Appointed by
Members

What this notice means

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Read more: What is Liquidation?.

All notices for Verso Biosense R&D Limited

3 Gazette notices on record for company no. 09890252, newest first. The full history, with last filed accounts, is on the Verso Biosense R&D Limited company record.

  1. Notices to creditors (MVL) 28 Sep 2026
  2. Resolution for winding up (MVL) 28 Sep 2026

How does this notice affect you?

Choose what applies and we'll point you at the right next step.

Would rather just talk? 020 7720 8000

Related guidance

Free, practical guides from K2 on what this kind of notice means for directors.

More liquidation notices

← Back to all notices

Frequently asked questions

Is Verso Biosense R&D Limited in financial difficulty?

No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Appointment of liquidators (MVL) for Verso Biosense R&D Limited (company no. 09890252) on 28 September 2026.

What does a Appointment of liquidators (MVL) mean?

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Who is dealing with the liquidation?

The office holders named in the notice: Nicola Kate Clark (IP No. 19390) of MHA Advisory Ltd, 80 Mosley Street, Manchester, M2 3FX; Andrew John Duncan (IP No. 9319) of MHA Advisory Ltd, 6th Floor, 2 L, appointed 23 September 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.

Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.